NS Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-49,131
Closed -$7.19M 113
2019
Q1
$7.19M Sell
49,131
-215
-0.4% -$31.2K 0.67% 54
2018
Q4
$6.6M Sell
49,346
-560
-1% -$91.8K 0.71% 53
2018
Q3
$9.51M Sell
49,906
-165
-0.3% -$30.3K 0.91% 47
2018
Q2
$8.35M Buy
50,071
+268
+0.5% +$43K 0.86% 49
2018
Q1
$8.38M Buy
49,803
+541
+1% +$90.7K 0.9% 48
2017
Q4
$8.06M Buy
49,262
+1,030
+2% +$185K 0.88% 51
2017
Q3
$9.88M Buy
48,232
+81
+0.2% +$18.8K 1.18% 36
2017
Q2
$11.7M Buy
48,151
+2,508
+5% +$589K 1.54% 20
2017
Q1
$10.9M Buy
45,643
+728
+2% +$170K 1.57% 17
2016
Q4
$9.43M Buy
44,915
+2,330
+5% +$483K 1.48% 17
2016
Q3
$9.81M Sell
42,585
-26
-0.1% -$6.35K 1.6% 13
2016
Q2
$9.85M Buy
42,611
+13,749
+48% +$3.17M 1.68% 15
2016
Q1
$7.74M Buy
28,862
+1,255
+5% +$359K 1.39% 21
2015
Q4
$8.63M Sell
27,607
-16,268
-37% -$4.84M 1.54% 18
2015
Q3
$11.9M Sell
43,875
-444
-1% -$136K 2.09% 7
2015
Q2
$13.4M Buy
+44,319
New +$13.2M 2.14% 6

Other funds holding AGN

NS Partners's AGN Position: Q2 2019 in Review

NS Partners sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 49,131 shares — an estimated $7.19M sold.

NS Partners first reported a position in AGN in Q2 2015 and held it in 16 quarters. The position peaked at $13.4M in Q2 2015. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • NS Partners reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • NS Partners sold 49,131 Allergan plc shares in Q2 2019, an estimated $7.19M.
  • NS Partners first reported a position in Allergan plc in Q2 2015 and held it in 16 quarters.
  • NS Partners's Allergan plc position peaked at $13.4M in Q2 2015.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on NS Partners's 13F filing for Q2 2019, filed 7 Aug 2019.